Pay in 4 interest-free payments of $5.42 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
Batch / lot current shipment Lot RT-509 Independent third-party Certificate of Analysis issued by Krause Analytical (dba Finnrick), Lab #207092, tested June 2026
The infusion skips that stage and delivers the full dose directly into the bloodstream
Not all applied product reaches target cells, so formulations include buffer above the minimum effective dose
Maximum healing benefit from the initial protocol
Most research-community protocols cap on-time at 4-6 weeks with at least equal time off between cycles
US$ 28.65
US$ 25.96
US$ 20.12
US$ 24.53
US$ 29.62
US$ 26.55
US$ 20.17
